The FDA approved twenty four new drugs during the first six months of 2020. Another twelve new drugs received approval through August 18th. The FDA reported approval of 48 novel investigational drugs in 2019, lower than the 59 approved in 2018, but still the third highest total in the past 25 years. There are another twenty-seven drugs due for approval (drugs with PDUFA Dates) before the end of the year making this year’s total potential approvals an all-time record of sixty-three new drugs approved.
Read on to review the list of 2020 FDA approvals covering a wide range of indications and some budget busters. We’ve included data about availability and pricing if it has been published. Pharmaceutical Pipeline Tracker subscribers are able to generate similar reports at any frequency they choose with much more detail, including safety and efficacy, from the knowledgebase if desired – a great tool for preparing for the P&T Committee meeting.
The unexpected costs of budget-busting new drugs are difficult to manage. A best practice for formulary management is to proactively monitor the pharmaceutical pipeline and review new drugs BEFORE they become available. A decision can be made on whether to add the drug or enact a therapeutic interchange. Unbiased information can be communicated to the medical staff regarding place in therapy, availability and/or restrictions. Why should someone use the Pharmaceutical Pipeline Tracker to augment current processes to monitor new drug developments? Rather than reviewing multiple data feeds, separating the wheat from the chaff, and preparing all the necessary summary data, Prescribe Right can do that work for you. Our 1,100+ Informational sources generate daily intelligence about the pharmaceutical pipeline from clinical journals, FDA announcements, medical conference summaries, presentations, industry newsletters, and pharmaceutical company announcements. CEO and Founder Scot Walker, PharmD, MS, BCPS, BCACP evaluates the evidence behind the hype creating and maintaining Monographs for each late stage investigational drug. Monographs include twelve descriptors plus efficacy and safety statements, news, analysis, and links to primary research via PubMed. Search an individual drug as well as lists of drugs by indication, drug class, therapy classification, manufacturer and PDUFA Date. EXPLORE 878 INVESTIGATIONAL DRUGS IN THE PHARMACEUTICAL PIPELINE TRACKER INCLUDING 29 IN LINE FOR APPROVAL BEFORE MID 2021. SUBSCRIBE, THEN USE ANY OF THE 10 SEARCH BUTTONS TO ACCESS DETAILED MONOGRAPHS AND CITATION LINKS, ALL FOR ONLY $339 FOR THE REMAINDER OF 2020 Click here for our economical subscription rates. Our best rate is less than $3 per day! Comments are closed.
|
Stay informed, subscribe to the
Prescribe Right Pharmaceutical Pipeline Tracker Latest Tweets from Prescribe Right
Archives
June 2023
|
Services |
Company |
Support |
© COPYRIGHT 2015. ALL RIGHTS RESERVED.
|